PCV has shown disparity in response to intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents when compared to typical AMD, and additional photodynamic therapy (PDT) and/or laser is often required. Here, VEGFA is linked to age-related macular degeneration.